Skip to main content
Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 0.110
Day High 0.125
Open:0.120
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. Its product portfolio includes SIAscopy, MoleMate, SIMSYS, MedX Home System, Rehab Portable Laser, Debtal Laser Console System and others. The company sells its products internationally, of which prime revenue is generated in Canada and the US.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

MedX Health Corp. Announces Non-Brokered Private Placement and Closing of First Tranche
- BusinessWire - Thu Jan 30, 7:52PM CST
BusinessWire - CMTX
Thu Jan 30, 7:52PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX-V:MDX) is pleased to announce that it has received Conditional Approval from the TSX Venture Exchange for a non-brokered Private Placement to accredited investors of up to 25,000,000 units at $0.12 per unit ("Unit"), to raise up to $3,000,000. Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common Share at the price of $0.20, exercisable for a period of two years from the date of issue. Closing of the Placement, which will take place in tranches, will be subject to receipt of subscriptions and a number of other conditions, including without limitation the receipt of all relevant regulatory and Stock Exchange approvals or acceptances. Qualified Agents may receive commissions in respect of subscriptions introduced by them by way of cash equal to 8% of funds so introduced, and issuance of agent's warrants ("Agent's Warrant(s)") equal in number to 8% of the number of units so subscribed for. Each Agent's Warrant, which is non-transferable, will be exercisable to acquire one Unit at $0.12 per Unit, at any time during the period of two years following the Closing.
MedX Health Corp. Announces Granting of Stock Options
- BusinessWire - Thu Jan 16, 9:37PM CST
BusinessWire - CMTX
Thu Jan 16, 9:37PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX), dedicated to the early detection of skin cancer, announces that a total of 5,990,000 stock options have been granted to directors (2,020,000 options), Officers (1,580,000 options) and employees and consultants (2,390,000 options). The options are all exercisable at the price of $0.17 per share, valid for a period to December 31, 2024, and vest immediately. The Company notes that a total of 7,150,000 stock options previously granted in 2014 expired unexercised on November 26, 2019. At this time there are a total of 21,200,000 options available for grant under the Company's Incentive Stock Option Plan, of which a total of 17,765,000 are currently subject to grants, at a weighted average exercise price of $0.197, and 3,435,000 remain available for grant under the Plan.
MedX Receives Major SIAScope(TM) Order for Launch of its DermSecure(TM) Telemedicine Platform in Brazil
- BusinessWire - Thu Jan 16, 7:00AM CST
BusinessWire - CMTX
Thu Jan 16, 7:00AM CST
MedX Health Corp. ("MedX") (TSX-V: MDX) announces that it has received an order for 500 SIAScope(TM) units for deployment on its DermSecure(TM) telemedicine platform from its exclusive Brazilian distributor, representing the single largest order in the Company's history.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.110 +4.55% increase
on 02/25/20
Period Open:0.130
Price movement based on the high, low and last over the given period.
0.135 -14.81% decrease
on 01/27/20
-0.015 (-11.54%) decrease
since 01/24/20
3-Month 0.095 +21.05% increase
on 12/13/19
Period Open:0.100
Price movement based on the high, low and last over the given period.
0.150 -23.33% decrease
on 01/17/20
+0.015 (+15.00%) increase
since 11/25/19
52-Week 0.090 +27.78% increase
on 10/09/19
Period Open:0.145
Price movement based on the high, low and last over the given period.
0.180 -36.11% decrease
on 03/11/19
-0.030 (-20.69%) decrease
since 02/25/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies